Mgr. Danica Michaličková, Ph.D., assistant professor
Contact information
· Institute of Pharmacology, First Faculty of Medicine, Albertov 4, Prague 2
· e-mail: danica.michalickova@lf1.cuni.cz
· telephone: +420 224 968 028
· ORCID ID: 0000-0002-9690-9846
· ResearcherID*: K-2824-2017
Research focus
pharmacometrics, population pharmacokinetics, evidence - based medicine, systematic reviews
Education
2012-2017 PhD, Department of Bromatology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
2007-2012 MSc, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
Professional membership
· Czech Medical Association of J. E. Purkyně, Czech Society for Experimental and Clinical Pharmacology and Toxicology
· European Society for Developmental Perinatal and Paediatric Pharmacology
Awards/Prizes
2021 Best publication in the category of clinical pharmacology awarded by Czech Society for Experimental and Clinical Pharmacology and Toxicology
Research fellowship
2018-2019 LACDR, Leiden, the Netherlands, 7 months
Selected publications
· Michalicková, D., Pokorná, P., Tibboel, D., et al. (2020). Rapid increase in clearance of phenobarbital in neonates on extracorporeal membrane oxygenation: a pilot retrospective population pharmacokinetic analysis. Pediatr Crit Care Med 21(9), e707-e715.
· Michaličková, D., Hartinger, J. M., Hladinová, Z., et al. (2022). Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy. Eur J Clin Pharmacol 78(1), 89-98.
· Hartinger, J. M., Michaličková, D., Dvořáčková, E., et al. (2023). Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications. Pharmaceutics 15(5), 1394.
· Pokorna, P., Michalickova, D., Tibboel, D., et al. (2024) Meropenem disposition in neonatal and pediatric extracorporeal membrane oxygenation. Antibiotics 13(5), 419.